Israel's Innovation Authority has chosen Nebius, via competitive bidding, to build the country's national supercomputer.1 But the decisive vote may come from Washington, not Jerusalem.
Like most sovereign AI buildouts, the project needs advanced chips such as Nvidia's, which fall under US export control rules.1 A delayed or denied license could stall construction or force Israel to redesign the system entirely.
Analysts rate this regulatory risk as major in severity, with medium likelihood, at 0.7 confidence.1 That puts real, though not certain, odds on disruption.
Israel joins a growing list of US allies discovering that sovereign compute ambitions run through Washington first. Gulf states including the UAE and Saudi Arabia have negotiated similar chip-access deals under close US scrutiny, and EU members have voiced frustration over their own limited access to top-tier AI hardware. Export approval, not local funding or engineering, has become the binding constraint.
Washington has tightened chip export rules in recent years mainly to contain China, but the friction spills over onto partners it favors. Even approved allies can face review delays, added licensing conditions, or rule changes as US chip policy shifts.
For Israel, more than one contract is at stake. The Innovation Authority ties the supercomputer to AI research, defense applications, and broader innovation funding.1 A stalled build would set back all three.
Nebius, as the chosen builder, now carries execution risk pegged to a regulatory timeline it doesn't control. If licenses are denied, its options narrow to sourcing alternative chips, redesigning the architecture, or delaying deployment.
The episode fits a wider pattern seen from Riyadh to Brussels: governments building sovereign AI infrastructure face a dependency they cannot engineer around, only negotiate.
No timeline for chip procurement or export license applications has been disclosed. The Innovation Authority has not indicated a contingency plan should licensing be delayed or denied.
